JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB313422

Anti-IGF2BP1/IMP1 antibody [RP23040259]

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Multiclonal IGF2BP1/IMP1 antibody. Suitable for ICC/IF, WB, RIP and reacts with Human, Mouse samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human IGF2BP1.

View Alternative Names

CRDBP, VICKZ1, ZBP1, IGF2BP1, Insulin-like growth factor 2 mRNA-binding protein 1, IGF2 mRNA-binding protein 1, IMP-1, IMP1, Coding region determinant-binding protein, IGF-II mRNA-binding protein 1, VICKZ family member 1, Zipcode-binding protein 1, CRD-BP, ZBP-1

3 Images
Immunocytochemistry/ Immunofluorescence - Anti-IGF2BP1/IMP1 Antibody [RP23040259] (AB313422)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-IGF2BP1/IMP1 Antibody [RP23040259] (AB313422)

Immunofluorescent analysis of HepG2 cells fixed with 4% formaldehyde reconstituted in 1X PBS for 10 min at room temperature and permeabilized with 0.1 % Triton X-100 in PBS for 15 min at room temperature labeling endogenous IGF2BP1/IMP1 with ab313422 at 1/100 dilution followed by Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 488 conjugate at 1/2000 dilution. Nuclei (blue) were stained using DAPI, and Rhodamine Phalloidin at 1/300 dilution was used for cytoskeletal F-actin (red) staining. Panel a-d) clearly demonstrates cytoplasmic localization of IGF2BP1/IMP1 in HepG2 cells. Panel e-h) shows no specific staining in HT29 cells which is IGF2BP1/IMP1 negative, demonstrating specificity. The images were captured at 60X magnification.

RIP - Anti-IGF2BP1/IMP1 Antibody [RP23040259] (AB313422)
  • RIP

Supplier Data

RIP - Anti-IGF2BP1/IMP1 Antibody [RP23040259] (AB313422)

Detection of binding of endogenous IGF2BP1/IMP1 protein to specific RNA using ab313422 : RNA Immunoprecipitation (RIP) was performed using ab313422 at 4 μg on clarified whole cell lysate from 2 million HepG2 cells. Normal Rabbit IgG was used as a negative IP control. Immunoprecipitated RNA was purified by an RNA Purification Kit and analyzed by RT-PCR using the Power SYBR Green RNA-to-CT 1-Step Kit with primer pairs over IGF2, MYC, ACTB mRNA (positive) and 18s rRNA (negative). Data is presented as the fraction of immunoprecipitated RNA (%IP) normalized to the total amount of RNA used for immunoprecipitation.

Western blot - Anti-IGF2BP1/IMP1 Antibody [RP23040259] (AB313422)
  • WB

Supplier Data

Western blot - Anti-IGF2BP1/IMP1 Antibody [RP23040259] (AB313422)

All lanes:

Western blot - Anti-IGF2BP1/IMP1 Antibody [RP23040259] (ab313422) at 1/1000 dilution

Lane 1:

HepG2 cell lysate at 30 µg

Lane 2:

PANC-1 cell lysate at 30 µg

Lane 3:

HeLa cell lysate at 30 µg

Lane 4:

IMR-32 cell lysate at 30 µg

Lane 5:

HT-29 cell lysate at 30 µg

Lane 6:

U-2 OS cell lysate at 30 µg

Lane 7:

NTERA-2 cell lysate at 30 µg

Lane 8:

NCCIT cell lysate at 30 µg

Lane 9:

F9 cell lysate at 30 µg

Lane 10:

Mouse Testis tissue lysate at 30 µg

Lane 11:

Mouse Liver tissue lysate at 30 µg

Secondary

All lanes:

Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/4000 dilution

Observed band size: 63 kDa

false

Key facts

Host species

Rabbit

Clonality

Multiclonal

Clone number

RP23040259

Isotype

IgG

Carrier free

No

Reacts with

Human, Mouse

Applications

WB, ICC/IF, RIP

applications

Immunogen

Synthetic Peptide within Human IGF2BP1. Database link Q9NZI8

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "RIP" : {"fullname" : "RIP", "shortname":"RIP"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "RIP-species-checked": "testedAndGuaranteed", "RIP-species-dilution-info": "2 µg for 10^6 Cells", "RIP-species-notes": "<p></p>" }, "Mouse": { "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "RIP-species-checked": "guaranteed", "RIP-species-dilution-info": "", "RIP-species-notes": "" } } }

Product details

What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:

  • - The sensitivity of polyclonal antibodies by recognising multiple epitopes
  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

View our range of recombinant multiclonal antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.09% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Preferentially binds to N6-methyladenosine (m6A)-containing mRNAs and increases their stability (PubMed : 29476152, PubMed : 32245947). Plays a direct role in the transport and translation of transcripts required for axonal regeneration in adult sensory neurons (By similarity). Regulates localized beta-actin/ACTB mRNA translation, a crucial process for cell polarity, cell migration and neurite outgrowth. Co-transcriptionally associates with the ACTB mRNA in the nucleus. This binding involves a conserved 54-nucleotide element in the ACTB mRNA 3'-UTR, known as the 'zipcode'. The RNP thus formed is exported to the cytoplasm, binds to a motor protein and is transported along the cytoskeleton to the cell periphery. During transport, prevents ACTB mRNA from being translated into protein. When the RNP complex reaches its destination near the plasma membrane, IGF2BP1 is phosphorylated. This releases the mRNA, allowing ribosomal 40S and 60S subunits to assemble and initiate ACTB protein synthesis. Monomeric ACTB then assembles into the subcortical actin cytoskeleton (By similarity). During neuronal development, key regulator of neurite outgrowth, growth cone guidance and neuronal cell migration, presumably through the spatiotemporal fine tuning of protein synthesis, such as that of ACTB (By similarity). May regulate mRNA transport to activated synapses (By similarity). Binds to and stabilizes ABCB1/MDR-1 mRNA (By similarity). During interstinal wound repair, interacts with and stabilizes PTGS2 transcript. PTGS2 mRNA stabilization may be crucial for colonic mucosal wound healing (By similarity). Binds to the 3'-UTR of IGF2 mRNA by a mechanism of cooperative and sequential dimerization and regulates IGF2 mRNA subcellular localization and translation. Binds to MYC mRNA, in the coding region instability determinant (CRD) of the open reading frame (ORF), hence preventing MYC cleavage by endonucleases and possibly microRNA targeting to MYC-CRD (PubMed : 29476152). Binding to MYC mRNA is enhanced by m6A-modification of the CRD (PubMed : 29476152). Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells. Binds to the oncofetal H19 transcript and to the neuron-specific TAU mRNA and regulates their localizations. Binds to and stabilizes BTRC/FBW1A mRNA. Binds to the adenine-rich autoregulatory sequence (ARS) located in PABPC1 mRNA and represses its translation. PABPC1 mRNA-binding is stimulated by PABPC1 protein. Prevents BTRC/FBW1A mRNA degradation by disrupting microRNA-dependent interaction with AGO2. Promotes the directed movement of tumor-derived cells by fine-tuning intracellular signaling networks. Binds to MAPK4 3'-UTR and inhibits its translation. Interacts with PTEN transcript open reading frame (ORF) and prevents mRNA decay. This combined action on MAPK4 (down-regulation) and PTEN (up-regulation) antagonizes HSPB1 phosphorylation, consequently it prevents G-actin sequestration by phosphorylated HSPB1, allowing F-actin polymerization. Hence enhances the velocity of cell migration and stimulates directed cell migration by PTEN-modulated polarization. Interacts with Hepatitis C virus (HCV) 5'-UTR and 3'-UTR and specifically enhances translation at the HCV IRES, but not 5'-cap-dependent translation, possibly by recruiting eIF3. Interacts with HIV-1 GAG protein and blocks the formation of infectious HIV-1 particles. Reduces HIV-1 assembly by inhibiting viral RNA packaging, as well as assembly and processing of GAG protein on cellular membranes. During cellular stress, such as oxidative stress or heat shock, stabilizes target mRNAs that are recruited to stress granules, including CD44, IGF2, MAPK4, MYC, PTEN, RAPGEF2 and RPS6KA5 transcripts.
See full target information IGF2BP1

Additional targets

Igf2bp1

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Open medicine (Warsaw, Poland) 20:20251191 PubMed40727611

2025

METTL3 blocked the progression of diabetic retinopathy through m6A-modified SOX2.

Applications

Unspecified application

Species

Unspecified reactive species

Xiujuan Chen,Qipeng Ling,Jie Xu,Yunyao Ye,Lili Dong

World journal of gastroenterology 30:5174-5190 PubMed39735272

2024

N6-methyladenosine-modified long non-coding RNA promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Yong Yu,Xiang-Hong Lu,Jin-Song Mu,Jiang-Yun Meng,Jiang-Shan Sun,Hai-Xu Chen,Yang Yan,Ke Meng
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com